Posted in | News

Magplane Finalizes Technical Planning to Build 1km 'Pre-Production Status' System

Magplane Technology, Inc. (Pink Sheets: MAGP) and its Inner Mongolia Joint Venture (JV) team have completed the testing phase of the demonstration system and finalized technical planning for construction of the fully functional 1 km "pre-production status" system.

Under the terms of agreements with the JV, Magplane will receive US$2 million for continued design and management services through this next phase of the MagPipe development that will enable construction of a deployed commercial system in 2010.

Dr. Bruce Montgomery, Chairman and Chief Technology Officer of Magplane, said "the 1km line demonstration design has been expanded to include numerous land topography features such as grade climbs and curves to simulate and encompass typical commercial installations. Using components to be produced for the commercial systems, the 1-km system will be fully tested to verify operation, reliability, and maintainability requirements under real-world conditions including continuous operation and power loss scenarios."

The Inner Mongolia Joint Venture has completed the first manufacturing building (100m x 40m) on its 32 acre site in the Baotou Hi-Tech Industrial Development Zone. The building, which includes two 20 meter overhead cranes that travel the length of the building, will initially be used to manufacture the 1-km system and then the first commercial systems. This new building also houses the MagPipe Short Demonstration System which was made operational in July and recently moved from its temporary location. The Short Demo will now be used to test specific components and generate long-lead data for certification of the first commercial MagPipe systems.

Source: http://www.magplane.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.